secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2026-06-04T20:18:37+00:00
Accession:  0001600620-26-000053
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia shareholders elect all five director nominees and approve auditor and say-on-pay at 2026 AGM
--------------------------------------------------------------------------------

- Five directors elected: Kevin Tang (96.59%), Jeffrey Bailey (95.33%), Kathy Goetz (96.52%), Craig Johnson (86.50%), Tina S. Nova (86.89%).
- PricewaterhouseCoopers LLP ratified as independent auditor with 89.14% votes for.
- Say-on-pay advisory resolution approved with 93.10% for, 6.05% against, 0.85% abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000160062026000053/0001600620-26-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000160062026000053/auph-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001600620-26-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer